What Do You Do When You Think A Vet’s Shoeing Prescription Won’t Help The Horse?

The Scenario: You’re ready to shoe a lame horse for the first time and the new client hands you a detailed and specific shoeing prescription from a vet you’ve never worked with. What do you do after you call the vet and he remains firm in what he wants done, even though you don’t think it will help the horse?

Options % of Farriers

Tell the owner he or she needs to find another farrier to do the work


Explain the situation and say you’re willing to work on other horses, but not this one


Shoe the horse the way the vet wants, but look for a new client as you can expect this to happen again


You give your written opinion and carry out the prescription exactly how the vet wants it


— 2017 American Farriers Journal email survey

If You Are Willing To Train A Horse To Stand For Hoof-Care, When Do You Do It?

Options % of Responding Farriers
During regular farrier visits 86%
During a designated training visit 14%

— 2017 American Farriers Journal email survey

Friday's Farrier Facts & Figures is brought to you by Markel Insurance.

Markel Corporation (NYSE – MKL) is a holding company for insurance, reinsurance, and investment operations around the world. Headquartered in Richmond, Virginia and founded in 1930, Markel reports its ongoing underwriting operations in three segments, and products originate from four insurance divisions and one reinsurance division. Markel Ventures, a subsidiary that makes strategic investments in companies outside of the insurance marketplace, is another important component of our business.

In each of our businesses, we seek to deliver innovative products and responsive customer service so that we can be a market leader. Our time horizon is long-term, our underwriting approach is disciplined, and our focus is on continuously improving the quality of the customer experience. Our financial goals are to earn consistent underwriting and operating profits and to combine those profits with superior investment returns to build shareholder value.